Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
Clinical trial NCT03516760 · TERMINATED
Trial details
- NCT number
- NCT03516760
- Sponsor
- AvenCell Europe GmbH
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-11
- Primary completion
- 2022-06-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.